BRASKEM SA
BRASKEM SA (BAK) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
• Braskem, Brazil's largest petrochemical company, is the classic case of a sound set of plants trapped under an unsound balance sheet: at $2.46 (July 19, 2026) the equity is worth near $2.0 billion, a thin claim sitting behind roughly $7.0 billion of net debt now inside a court-supervised financial restructuring. • The real risk is the capital structure, not the crackers: first-quarter 2026 shareholders' equity was negative about R$16.2 billion with a going-concern warning attached [Source: Bra
Is BAK overvalued? See what's priced in →
63 institutional managers reported holding BAK in 13F filings for the quarter ended 2026-03-31. Together they hold about 1% of the company; the top 10 hold 1%. 23 opened new positions that quarter. Held by Marshall Wace, Jane Street, Vanguard Group, among others. On the short side, 4.5M shares were sold short as of the 2026-06-15 count, about 0.6% of shares outstanding (1.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
It pays a dividend. Cash returned over the past three years: $2.55M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Last analyzed: July 19, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.